title: Fractional dynamics pharmacokinetics-pharmacodynamic models.
abstract: While an increasing number of fractional order integrals and differential equations applications have been reported in the physics, signal processing, engineering and bioengineering literatures, little attention has been paid to this class of models in the pharmacokinetics-pharmacodynamic (PKPD) literature. One of the reasons is computational: while the analytical solution of fractional differential equations is available in special cases, it this turns out that even the simplest PKPD models that can be constructed using fractional calculus do not allow an analytical solution. In this paper, we first introduce new families of PKPD models incorporating fractional order integrals and differential equations, and, second, exemplify and investigate their qualitative behavior. The families represent extensions of frequently used PK link and PD direct and indirect action models, using the tools of fractional calculus. In addition the PD models can be a function of a variable, the active drug, which can smoothly transition from concentration to exposure, to hyper-exposure, according to a fractional integral transformation. To investigate the behavior of the models we propose, we implement numerical algorithms for fractional integration and for the numerical solution of a system of fractional differential equations. For simplicity, in our investigation we concentrate on the pharmacodynamic side of the models, assuming standard (integer order) pharmacokinetics.
authors.affiliation: Department of Bioengineering and Therapeutic Sciences, University of California, Box 0912, San Francisco, CA, USA. davide.verotta@ucsf.edu
authors.forename: Davide
authors.initials: D
authors.lastname: Verotta
mesh_terms: D004341:Drug Evaluation / Q000379:methods*; D008954:Models, Biological; D008962:Models, Theoretical
references.citation: Crit Rev Biomed Eng. 2004;32(2):105-93
references.pmid: 15373276
references.citation: Biometrics. 1990 Sep;46(3):673-87
references.pmid: 2242409
references.citation: Farmaco Sci. 1968 Oct;23(10):907-18
references.pmid: 5712792
references.citation: J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):501-20
references.pmid: 16320102
references.citation: J Pharmacokinet Biopharm. 1993 Aug;21(4):457-78
references.pmid: 8133465
references.citation: Biophys J. 1995 Jan;68(1):46-53
references.pmid: 7711266
references.citation: Drug Metab Dispos. 2009 Feb;37(2):386-90
references.pmid: 19022942
references.citation: J Pharmacokinet Pharmacodyn. 2002 Aug;29(4):383-402
references.pmid: 12518710
references.citation: J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):227-79
references.pmid: 16404503
references.citation: Crit Rev Biomed Eng. 2004;32(3-4):195-377
references.pmid: 15651636
references.citation: Am J Physiol. 1990 Apr;258(4 Pt 1):E727-36
references.pmid: 2333964
references.citation: J Pharmacokinet Pharmacodyn. 2010 Apr;37(2):209-15; discussion 217-20
references.pmid: 20405313
references.citation: J Pharmacokinet Pharmacodyn. 2009 Apr;36(2):165-78
references.pmid: 19340400
references.citation: J Pharmacokinet Pharmacodyn. 2010 Apr;37(2):119-34
references.pmid: 20072802